Understanding the molecular mechanism of memory from single-cell gene expression to protein folding
从单细胞基因表达到蛋白质折叠理解记忆的分子机制
基本信息
- 批准号:10392436
- 负责人:
- 金额:$ 13.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAmericanAttentionAutopsyAwardBehavioralCellsChromatinCognitive deficitsComputer AnalysisDataDementiaDiseaseDominant-Negative MutationDorsalEnsureExhibitsFamilyFoundationsFunctional disorderFutureGRP78 geneGene ExpressionGene Expression ProfileGene TargetingGenesGenetic TranscriptionGenomic SegmentGoalsGrantHippocampus (Brain)HomeHumanImpaired cognitionIndividualInstitutionInterviewIowaLabelLaboratoriesLeadLearningLinkLocationMemoryMemory LossMemory impairmentMentorsMolecularMolecular BiologyMolecular ChaperonesMusNR4A1 geneNR4A2 geneNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsPathogenesisPathologicPathway interactionsPatternPeer ReviewPersonsPharmacologyPhasePlayPopulationPreparationProcessProtein BiosynthesisProteinsProteomicsPsychiatryRNARegulationResearchResearch PersonnelResolutionRoleRunningSamplingTauopathiesTechnologyTestingTherapeuticTimeTrainingTranscriptTranscriptional RegulationTransgenesTransgenic MiceTranslatingUniversitiesViralWorkWorld Health OrganizationWritingagedbasebehavioral pharmacologycareercell typecognitive functioncollaborative environmentcostdesigndifferential expressiondisabilityenhancing factorexperimental studygene inductiongenetic manipulationinsightlong term memorymemory consolidationmemory processmouse modelmutantoverexpressionprotein foldingprotein functionsingle cell analysissingle-cell RNA sequencingskillssocioeconomicsspatial memorytau Proteinstau aggregationtherapeutic targettooltraffickingtranscription factortranscriptomics
项目摘要
Project Summary / Abstract
Deficits in cognitive function and memory are a debilitating aspect of neurodegenerative disease resulting in
long-term disability, enormous suffering to individuals and their families, and significant socioeconomic cost.
Currently, more than 16 million Americans live with cognitive impairment, and this number is expected to continue
rising as the number of individuals affected by Alzheimer's disease and related dementias is predicted to double
by 2060. Long-term memory consolidation requires the induction of gene expression in a specific temporal
pattern. Newly synthesized transcripts are translated and folded into functional proteins and then trafficked to
the correct cellular location. Dysfunction in any of these steps can lead to memory impairment and may be
dysregulated in disease conditions, although the precise mechanisms by which this occurs are unclear. My long-
term goal is to determine the specific molecular mechanisms through which the Nr4A sub-family regulates gene
expression to control long-term memory in order to develop therapeutic tools to treat AD, which I will pursue as
an independent investigator at a research-focused institution. The overall objective of this proposal is to
determine the mechanisms that link transcriptional regulation and protein folding during memory formation and
how the disruption of these processes contributes to cognitive impairment in Alzheimer's disease. My central
hypothesis is that Nr4A regulates genes in specific cell types to facilitate protein folding and memory formation.
I will test this through the following three aims: Specific Aim 1 (K99): identify cell-type specific transcriptional
signatures of memory and identify direct gene targets of Nr4A during memory consolidation using a single-cell
RNA sequencing approach; Specific Aim 2 (K99): determine the role of an Nr4A target, the protein folding
chaperone Hspa5, in memory consolidation and identify its downstream protein targets; Specific Aim 3 (R00):
determine the effect of activating Nr4A transcription factors on memory deficits and gene expression in a mouse
model of Alzheimer's disease. This project provides training in cutting-edge research skills, including
computational analysis of single cell data and chromatin enrichment in memory research. The University of Iowa
is home to experts on memory, computational psychiatry, neurodegeneration, and molecular biology, and the
collaborative environment provides an ideal setting in which to obtain the necessary skills that will allow me to
transition into a successful independent research career. As such, during the mentored (K99) phase, I will
engage in activities designed to prepare me to successfully achieve independence, including training in scientific
presentations, laboratory management skills, grant writing tools, scientific peer-review, and interview/application
preparation. Collectively, this award will provide me with the cutting-edge skills and expertise in molecular
biology, neurodegeneration and behavioral pharmacology necessary to ensure a strong technical and
conceptual foundation to start my independent laboratory investigating mechanisms for the treatment of
Alzheimer's disease.
项目概要/摘要
认知功能和记忆缺陷是神经退行性疾病的一个令人衰弱的方面,导致
长期残疾,给个人及其家庭带来巨大痛苦,以及巨大的社会经济成本。
目前,超过 1600 万美国人患有认知障碍,并且这一数字预计将持续下去
随着阿尔茨海默病和相关痴呆症患者数量预计将增加一倍,这一数字也会上升
到 2060 年。长期记忆巩固需要在特定时间诱导基因表达
图案。新合成的转录物被翻译并折叠成功能蛋白,然后被运输到
正确的蜂窝位置。这些步骤中任何一个的功能障碍都可能导致记忆障碍,并可能
在疾病条件下失调,尽管发生这种情况的确切机制尚不清楚。我的长-
长期目标是确定 Nr4A 亚家族调节基因的具体分子机制
控制长期记忆的表达,以开发治疗 AD 的治疗工具,我将以此为目标
以研究为重点的机构的独立调查员。该提案的总体目标是
确定记忆形成过程中转录调控和蛋白质折叠之间的联系机制
这些过程的破坏如何导致阿尔茨海默病的认知障碍。我的中央
假设 Nr4A 调节特定细胞类型中的基因以促进蛋白质折叠和记忆形成。
我将通过以下三个目标来测试这一点: 具体目标 1 (K99):识别细胞类型特异性转录
使用单细胞在记忆巩固过程中识别记忆特征并识别 Nr4A 的直接基因目标
RNA测序方法;具体目标 2 (K99):确定 Nr4A 靶标的作用,即蛋白质折叠
伴侣 Hspa5,参与记忆巩固并确定其下游蛋白质靶标;具体目标 3 (R00):
确定激活 Nr4A 转录因子对小鼠记忆缺陷和基因表达的影响
阿尔茨海默病模型。该项目提供尖端研究技能的培训,包括
记忆研究中单细胞数据和染色质富集的计算分析。爱荷华大学
是记忆、计算精神病学、神经退行性疾病和分子生物学专家的所在地
协作环境提供了一个理想的环境,让我能够获得必要的技能
过渡到成功的独立研究生涯。因此,在指导(K99)阶段,我将
参加旨在帮助我成功实现独立的活动,包括科学培训
演示、实验室管理技能、资助写作工具、科学同行评审和面试/申请
准备。总的来说,这个奖项将为我提供分子生物学方面的尖端技能和专业知识
生物学、神经退行性变和行为药理学是确保强大的技术和能力所必需的
启动我的独立实验室研究治疗机制的概念基础
阿尔茨海默病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Snehajyoti Chatterjee其他文献
Snehajyoti Chatterjee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Snehajyoti Chatterjee', 18)}}的其他基金
Understanding the molecular mechanism of memory from single-cell gene expression to protein folding
从单细胞基因表达到蛋白质折叠理解记忆的分子机制
- 批准号:
10885556 - 财政年份:2021
- 资助金额:
$ 13.25万 - 项目类别:
Understanding the molecular mechanism of memory from single-cell gene expression to protein folding
从单细胞基因表达到蛋白质折叠理解记忆的分子机制
- 批准号:
10215185 - 财政年份:2021
- 资助金额:
$ 13.25万 - 项目类别:
相似国自然基金
来源和老化过程对大气棕碳光吸收特性及环境气候效应影响的模型研究
- 批准号:42377093
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
光老化微塑料持久性自由基对海洋中抗生素抗性基因赋存影响机制
- 批准号:42307503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
任务切换影响相继记忆的脑机制:基于认知老化的视角
- 批准号:32360201
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
生物炭介导下喀斯特耕地土壤微塑料老化及其对Cd有效性的影响机制
- 批准号:42367031
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
生物炭原位修复底泥PAHs的老化特征与影响机制
- 批准号:42307107
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 13.25万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 13.25万 - 项目类别:
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 13.25万 - 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
- 批准号:
10644253 - 财政年份:2023
- 资助金额:
$ 13.25万 - 项目类别:
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
镰状细胞病的克隆造血和遗传变异
- 批准号:
10638404 - 财政年份:2023
- 资助金额:
$ 13.25万 - 项目类别: